NAVIDEA BIOPHARMACEUTICALS SIGNS LETTER OF INTENT WITH WORLDCARE CLINICAL TO PARTNER ON NAVIDEA’S RHEUMATOID ARTHRITIS CLINICAL IMAGING WORKFLOW AND COMMERCIALIZATION

NAVIDEA BIOPHARMACEUTICALS SIGNS LETTER OF INTENT WITH WORLDCARE CLINICAL TO PARTNER ON NAVIDEA’S RHEUMATOID ARTHRITIS CLINICAL IMAGING WORKFLOW AND COMMERCIALIZATION

DUBLIN, Ohio–(BUSINESS WIRE)– Navidea Biopharmaceuticals,Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused onthe development of precision immunodiagnostic agents and immunotherapeutics,today announced that it has signed a letter of intent (“LOI”) to partner withWorldCare …

Leave a Reply